Please login to the form below

Not currently logged in
Email:
Password:

Itulazax

This page shows the latest Itulazax news and features for those working in and with pharma, biotech and healthcare.

ALK-Abello debuts its birch pollen allergy therapy in Germany

ALK-Abello debuts its birch pollen allergy therapy in Germany

Key market for the new product. Danish drugmaker ALK-Abello has launched its tree pollen immunotherapy Itulazax in Germany, its first market, following its European approval earlier this year. ... The company expects to roll Itulazax out next in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics